Gotaro Yamada

Summary

Affiliation: Kawasaki Medical School
Country: Japan

Publications

  1. ncbi Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors
    Gotaro Yamada
    Department of Internal Medicine, Kawasaki Medical School, Kawasaki Hospital, Okayama, Japan
    Clin Drug Investig 28:9-16. 2008
  2. ncbi Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma
    Sabina Mahmood
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama City 2 1 80, Okayama 700 0986, Japan
    Liver Int 25:220-5. 2005
  3. ncbi Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis
    Nobuyuki Toshikuni
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama, Japan
    J Gastroenterol Hepatol 24:1276-83. 2009
  4. ncbi [Clinical aspects of liver cirrhosis, type B]
    Gotaro Yamada
    Department of Internal Medicine, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical School
    Nippon Rinsho 62:349-53. 2004
  5. ncbi Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C
    Sabina Mahmood
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama, Japan
    Free Radic Res 37:781-5. 2003
  6. ncbi Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C
    Sabina Mahmood
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama 700 0986, Japan
    Antioxid Redox Signal 6:19-24. 2004
  7. ncbi Wilson's disease masquerading as nonalcoholic steatohepatitis
    Sabina Mahmood
    Department of Internal Medicine and Clinical Research, Center for Liver Disease, Kawasaki Medical School, Kawasaki Hospital, Okayama, Japan
    N Am J Med Sci 1:74-6. 2009
  8. ncbi Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
    Takeji Umemura
    Department of Internal Medicine, Hepatology, and Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan
    Clin Infect Dis 47:e52-6. 2008
  9. ncbi [Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH]
    Miwa Kawanaka
    Department of General Internal Medicine 2, KawKawasaki Medical School, Japan
    Nihon Shokakibyo Gakkai Zasshi 109:2042-8. 2012
  10. ncbi [Histopathological characteristics and clinical significance of New Inuyama Classification in chronic hepatitis B]
    Gotaro Yamada
    Department of Internal Medicine, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical School
    Nippon Rinsho 62:290-2. 2004

Collaborators

Detail Information

Publications14

  1. ncbi Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors
    Gotaro Yamada
    Department of Internal Medicine, Kawasaki Medical School, Kawasaki Hospital, Okayama, Japan
    Clin Drug Investig 28:9-16. 2008
    ..e. sex, age, baseline HCV RNA level, bodyweight and fibrosis stage) and peginterferon (PEG IFN)-alpha-2a plus ribavirin dose reductions on SVR rates...
  2. ncbi Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma
    Sabina Mahmood
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama City 2 1 80, Okayama 700 0986, Japan
    Liver Int 25:220-5. 2005
    ..Hepatitis B virus (HBV) is an important factor in the development of hepatocellular carcinoma (HCC). We studied the influence of HBV viral load on HCC occurrence in HBV related liver cirrhosis (LC)...
  3. ncbi Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis
    Nobuyuki Toshikuni
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama, Japan
    J Gastroenterol Hepatol 24:1276-83. 2009
    ..The natural history of alcoholic cirrhosis, especially in Asian countries, has not been completely understood thus far...
  4. ncbi [Clinical aspects of liver cirrhosis, type B]
    Gotaro Yamada
    Department of Internal Medicine, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical School
    Nippon Rinsho 62:349-53. 2004
  5. ncbi Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C
    Sabina Mahmood
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama, Japan
    Free Radic Res 37:781-5. 2003
    ..Therefore, Vit. E can act as a supportive therapy to combat liver damage caused by oxidative stress, in such patients with continuously high levels of ALT even after anti-viral and anti-inflammatory drug therapy...
  6. ncbi Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C
    Sabina Mahmood
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, Okayama 700 0986, Japan
    Antioxid Redox Signal 6:19-24. 2004
    ..Detection of OS markers may be important for monitoring disease progression in HCV patients. Antioxidant therapy in combination with antiviral therapy may minimize liver damage and aid in the prevention and subsequent development of HCC...
  7. ncbi Wilson's disease masquerading as nonalcoholic steatohepatitis
    Sabina Mahmood
    Department of Internal Medicine and Clinical Research, Center for Liver Disease, Kawasaki Medical School, Kawasaki Hospital, Okayama, Japan
    N Am J Med Sci 1:74-6. 2009
    ..Wilson's disease is one of the most common hereditary causes of unclear hepatopathy. PATIENT #ENTITYSTARTX00026;..
  8. ncbi Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
    Takeji Umemura
    Department of Internal Medicine, Hepatology, and Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan
    Clin Infect Dis 47:e52-6. 2008
    ..Because one-fourth of cases develop into fulminant hepatic failure and mortality is 100%, management of HBV reactivation in patients with resolved HBV infection should be discussed...
  9. ncbi [Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH]
    Miwa Kawanaka
    Department of General Internal Medicine 2, KawKawasaki Medical School, Japan
    Nihon Shokakibyo Gakkai Zasshi 109:2042-8. 2012
    ....
  10. ncbi [Histopathological characteristics and clinical significance of New Inuyama Classification in chronic hepatitis B]
    Gotaro Yamada
    Department of Internal Medicine, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical School
    Nippon Rinsho 62:290-2. 2004
  11. ncbi Association of primary biliary cirrhosis with idiopathic thrombocytopenic purpura
    Nobuyuki Toshikuni
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, 2 1 80 Nakasange, Okayama 7008505, Japan
    World J Gastroenterol 14:2451-3. 2008
    ..This case suggests common immunogenetic factors might be involved in the development of PBC and ITP...
  12. ncbi Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine
    Haruhiko Kobashi
    Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama Department of Clinical Research, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical School, Kawasaki Department of Internal Medicine, Tsuyama Central Hospital, Tsuyama, Japan
    Hepatol Res 41:405-16. 2011
    ..Conclusion:  NA exerted a long-term efficacy and improved hepatic reservation in CHB and cirrhosis. After NA treatment, AFP dropped to lower than 10 ng/mL with marked elevation of specificity, leading to an earlier detection of HCC...
  13. ncbi Effect of TT virus co-infection on interferon response in chronic hepatitis C patients
    Miwa Kawanaka
    Department of Internal Medicine, Center for Liver Diseases, Kawasaki Hospital, Kawasaki Medical School, 2 1 80 Nakasange, Okayama City 700 8505, Japan
    Liver 22:351-5. 2002
    ....
  14. ncbi Vitamin E supplementation increases polyunsaturated fatty acids of RBC membrane in HCV-infected patients
    Yasuko Ota
    Department of Nutritional Science, Faculty of Health and Welfare Science, Okayama Prefectural University, Soja, Japan
    Nutrition 20:358-63. 2004
    ..We investigated the effects of vitamin E supplementation on the fatty acid composition of red blood cell membrane phospholipids and on the clinical observations in patients with hepatitis C virus...